## Core Concept
Hybridoma technology is a method used to produce large quantities of monoclonal antibodies. It involves the fusion of an antibody-producing B cell with a myeloma (cancer) cell that can grow indefinitely in the lab. This fusion cell, or hybridoma, can produce a single type of antibody (monoclonal) in large quantities.

## Why the Correct Answer is Right
The correct answer is related to the characteristics and applications of hybridoma technology. Monoclonal antibodies produced by hybridomas are highly specific, can be produced in large quantities, and have various applications in research, diagnostics, and therapy. One key aspect of hybridoma technology is that the hybridoma cells can proliferate indefinitely in vitro, allowing for continuous production of the desired antibody.

## Why Each Wrong Option is Incorrect
- **Option A:** This option is not provided, but typically, correct statements about hybridoma technology might include its use in producing monoclonal antibodies, the process involving B cell and myeloma cell fusion, and applications in medicine and research.
- **Option B:** Similarly, without the content of Option B, we can't directly address its incorrectness, but any statement contradicting established facts about hybridoma technology (like the specificity of monoclonal antibodies, the process of cell fusion, or the immortality of hybridoma cells) would be incorrect.
- **Option C:** This option's content is also missing, but any statement that does not align with how hybridoma technology works or its applications would be considered incorrect.
- **Option D:** Without specific details on Option D, we acknowledge that in the context of hybridoma technology, incorrect statements might involve misconceptions about the technology's capabilities, the nature of monoclonal antibodies, or the process of generating hybridomas.

## Clinical Pearl / High-Yield Fact
A key point to remember is that hybridoma technology allows for the production of **monoclonal antibodies**, which are crucial for targeted therapies, diagnostic tools, and research. Understanding the specificity and potential applications of these antibodies is vital for any aspiring medical professional.

## Correct Answer Line
Given that the question and specific options A, B, C, and D are not detailed, the explanation focuses on the general principles of hybridoma technology. However, based on the instruction:

**Correct Answer: D.**